Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.20p
   
  • Change Today:
      0.050p
  • 52 Week High: 11.85
  • 52 Week Low: 3.82
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 1,526,850
  • Market Cap: £22.40m

Eden Research surges as botrytis grape product authorised in Malta

Date: Tuesday 26 May 2015

LONDON (ShareCast) - Shares in Eden Research surged on Tuesday as it announced that 3AEY, its first product, has been authorised to treat botrytis in table and wine grapes by Malta's regulator.
Malta is acting as the Southern EU agricultural zone's zonal rapporteur, by which it is the first EU country to assess the product, although Eden is confident that remaining member states in the zone will grant similar approval for the sale and use of 3EY within the next four months.

"As our licensees, partners and shareholders well know, we have been pursuing the authorisation to sell 3AEY in the EU Southern Zone for nearly eight years," said chief executive officer Sean Smith in a statement. "This is not only excellent news for our licensees, but also for Eden."

As of 12:15 BST, shares in Eden Research were trading 31.88% higher at 14.62p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 4.20p
Change Today 0.050p
% Change 1.20 %
52 Week High 11.85
52 Week Low 3.82
Volume 1,526,850
Shares Issued 533.35m
Market Cap £22.40m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.37% below the market average17.37% below the market average17.37% below the market average17.37% below the market average17.37% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average
Price Trend
21.6% below the market average21.6% below the market average21.6% below the market average21.6% below the market average21.6% below the market average
16.98% above the sector average16.98% above the sector average16.98% above the sector average16.98% above the sector average16.98% above the sector average
Income Not Available
Growth
49.00% above the market average49.00% above the market average49.00% above the market average49.00% above the market average49.00% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

Eden Research Dividends

No dividends found

Trades for 14-Jun-2024

Time Volume / Share Price
15:59 596,915 @ 4.40p
15:05 459,563 @ 4.35p
14:52 7,933 @ 4.08p
14:46 12,737 @ 4.08p
14:37 13,833 @ 3.82p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page